Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7 (4), 494-506

Reactive Astrocytes as Therapeutic Targets for CNS Disorders


Reactive Astrocytes as Therapeutic Targets for CNS Disorders

Mary E Hamby et al. Neurotherapeutics.


Reactive astrogliosis has long been recognized as a ubiquitous feature of CNS pathologies. Although its roles in CNS pathology are only beginning to be defined, genetic tools are enabling molecular dissection of the functions and mechanisms of reactive astrogliosis in vivo. It is now clear that reactive astrogliosis is not simply an all-or-nothing phenomenon but, rather, is a finely gradated continuum of molecular, cellular, and functional changes that range from subtle alterations in gene expression to scar formation. These changes can exert both beneficial and detrimental effects in a context-dependent manner determined by specific molecular signaling cascades. Dysfunction of either astrocytes or the process of reactive astrogliosis is emerging as an important potential source of mechanisms that might contribute to, or play primary roles in, a host of CNS disorders via loss of normal or gain of abnormal astrocyte activities. A rapidly growing understanding of the mechanisms underlying astrocyte signaling and reactive astrogliosis has the potential to open doors to identifying many molecules that might serve as novel therapeutic targets for a wide range of neurological disorders. This review considers general principles and examines selected examples regarding the potential of targeting specific molecular aspects of reactive astrogliosis for therapeutic manipulations, including regulation of glutamate, reactive oxygen species, and cytokines.

Similar articles

  • Astrocytes: biology and pathology.
    Sofroniew MV, Vinters HV. Sofroniew MV, et al. Acta Neuropathol. 2010 Jan;119(1):7-35. doi: 10.1007/s00401-009-0619-8. Epub 2009 Dec 10. Acta Neuropathol. 2010. PMID: 20012068 Free PMC article. Review.
  • Molecular dissection of reactive astrogliosis and glial scar formation.
    Sofroniew MV. Sofroniew MV. Trends Neurosci. 2009 Dec;32(12):638-47. doi: 10.1016/j.tins.2009.08.002. Epub 2009 Sep 24. Trends Neurosci. 2009. PMID: 19782411 Free PMC article. Review.
  • Astrogliosis.
    Sofroniew MV. Sofroniew MV. Cold Spring Harb Perspect Biol. 2014 Nov 7;7(2):a020420. doi: 10.1101/cshperspect.a020420. Cold Spring Harb Perspect Biol. 2014. PMID: 25380660 Free PMC article. Review.
  • Pathophysiology of astroglial purinergic signalling.
    Franke H, Verkhratsky A, Burnstock G, Illes P. Franke H, et al. Purinergic Signal. 2012 Sep;8(3):629-57. doi: 10.1007/s11302-012-9300-0. Epub 2012 May 1. Purinergic Signal. 2012. PMID: 22544529 Free PMC article. Review.
  • Astrocytes: a central element in neurological diseases.
    Pekny M, Pekna M, Messing A, Steinhäuser C, Lee JM, Parpura V, Hol EM, Sofroniew MV, Verkhratsky A. Pekny M, et al. Acta Neuropathol. 2016 Mar;131(3):323-45. doi: 10.1007/s00401-015-1513-1. Epub 2015 Dec 15. Acta Neuropathol. 2016. PMID: 26671410 Review.
See all similar articles

Cited by 126 articles

See all "Cited by" articles

Publication types

MeSH terms